Joshua D. Schiffman, M.D.

Locations

Schedule An Appointment	Clinical Office Address
(801) 585-0100	Huntsman Cancer Hospital 1950 Circle of Hope Salt Lake City, UT 84112 Map
(801) 662-4700	Primary Children's Hospital Pediatric Hematology/Oncology 100 N Mario Capecchi Drive Salt Lake City, UT 84113

Bio

Dr. Schiffman received his medical degree from Brown University School of Medicine, completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University. He has been an investigator at the Huntsman Cancer Institute since 2008, and a faculty member at the University of Utah since 2009. Dr. Schiffman is board-certified in Pediatrics and Pediatric Hematology-Oncology.

He is currently an Associate Professor of Pediatrics at the University of Utah, an Adjunct Associate Professor in the Department of Oncological Sciences, and is in the Division of Hematology/Oncology at Primary Children´s Medical Center. He serves as the Medical Director of the High Risk Pediatric Cancer Clinic at Huntsman Cancer Institute where he cares for children and families with inherited risk for cancer. His specific clinical interests are cancer susceptibility in families, with a focus on the genomic changes necessary for cancer development.

Dr. Schiffman’s work in the High Risk Pediatric Cancer Clinic contributed to a landmark study in the field of clinical cancer genetics demonstrating that early cancer surveillance in families with Li-Fraumeni Syndrome significantly improves overall survival. He continues to work with children and families at high risk for cancer development to discover genes that may be targeted for both prevention and treatment of childhood cancer. Dr. Schiffman is also the Education Director for the Program in Personalized Health Care at the University of Utah, where he oversees the teaching of personalized medicine to physicians and their patients.

Board Certification and Academic Information

Academic Departments	Pediatrics - Associate Professor Oncological Sciences - Adjunct Associate Professor
Academic Divisions	Pediatric Hematology/Oncology
Board Certification	American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Board Certification and Academic Information

Academic Departments	Pediatrics - Associate Professor Oncological Sciences - Adjunct Associate Professor
Academic Divisions	Pediatric Hematology/Oncology
Board Certification	American Board of Pediatrics (Sub: Ped Hematology-Oncology)

Academic Office Locations

Academic Office Phone Number	Academic Office Address
(801) 587-4745	Huntsman Cancer Institute 2000 Circle of Hope Salt Lake City, UT 84112

Academic Bio

Joshua Schiffman, M.D., is an Associate Professor in the Department of Pediatrics and an Adjunct Associate Professor in the Department of Oncological Sciences in the School of Medicine at the University of Utah. He is an investigator in the Huntsman Cancer Institute and a member of the Nuclear Control of Cell Growth and Differentiation program. Since 2008, Dr. Schiffman has served as the Medical Director of the High Risk Pediatric Cancer Clinic, which is run through both Primary Children’s Medical Center and Huntsman Cancer Institute. He is the Education Director for the Program in Personalized Health Care at the University of Utah, and he oversaw the Translational Oncology Core (TOC) at HCI, which analyzes clinical samples from patients to identify targetable changes in tumors.

Dr. Schiffman is dedicated to translating biological and genomic discoveries into clinical advances for patients. His research emphasis is cancer susceptibility in families, with a focus on the genomic changes underlying pediatric cancer development. He is pursuing copy number changes related to leukemia and sarcoma development, and functional assays related to risk of hereditary cancers. He is involved with the Utah Population Database (UPDB) to understand the risk factors associated with cancer development in children and their families. Dr. Schiffman runs a translational genomics research laboratory, where he combines both epidemiological and comparative oncology perspectives to advance the understanding of why children develop cancer. Dr. Schiffman is a member of several national and international research cooperative groups related to cancer risk and genetic epidemiology. He is also the Principal Investigator of the Cancer Genetics Study (CGS) which enrolls high risk families for genomic analysis.

Schiffman earned his MD from Brown University, and completed his Pediatric Residency, Pediatric Chief Residency, and Pediatric Hematology/Oncology Fellowship at Stanford University, where he then served as an Instructor and directed the Pediatric Cancer Genetics Clinic (PCGC). In 2008, he joined the University of Utah as an Instructor, as well as an Investigator at Huntsman Cancer Institute. Within one year, he had risen to Assistant Professor in Pediatrics, and was promoted to Associate Professor in 2012. Dr. Schiffman has written more than 150 publications, scientific papers, chapters, and abstracts.

Education History

Type	School	Degree
Graduate Training	University of Utah Clinical Investigation (Genetics)	M.Sc.
Fellowship	Stanford University Medical Center Pediatric Hematology/Oncology	Fellow
Residency	Stanford University Medical Center Chief Medical Resident	Resident
Residency	Stanford University Medical Center Pediatrics	Resident
Internship	Stanford University School of Medicine Pediatrics	Intern
Professional Medical	Brown University School of Medicine Medicine	M.D.
Undergraduate	Brown University Psychology/Biology	B.S.

Selected Provider Publications

Journal Article

1. Schiffman JD, Geller JI, Mundt E, Means A, Means L, Means (2013)Update on pediatric cancer predisposition syndromes.  Pediatric Blood & Cancer, 60(8),1247-52
2. Curtin K, Smith KR, Fraser A, Pimentel R, Kohlmann W, Schiffman J(2013)Familial risk of childhood cancer and tumors in the Li-Fraumeni spectrum in the Utah Population Database: implications for genetic evaluation in pediatric practice.  International Journal of Cancer (electronic), 133(10),2444-53
3. Testa JR, Malkin D, Schiffman J(2013)Connecting molecular pathways to hereditary cancer risk syndromes.  American Society of Clinical Oncology educational book, 201381-90
4. Mangum DS, Downie J, Mason CC, Jahromi MS, Joshi D, Rodic V, Muschen M, Meeker N, Trede N, Frazer JK, Zhou Y, Cheng C, Jeha S, Pui CH, Willman CL, Harvey RC, Hunger SP, Yang JJ, Barnette P, Mullighan CG, Miles RR, Schiffman J(2013)VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.LID - 10.1038/leu.2013.223 [doi]  Leukemia,
5. Jasperson KW, Kohlmann W, Gammon A, Slack H, Buchmann L, Hunt J, Kirchhoff AC, Baskin H, Shaaban A, Schiffman J(2013)Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.  Familial Cancer,
6. Jahromi MS, Putnam AR, Druzgal C, Wright J, Spraker-Perlman H, Kinsey M, Zhou H, Boucher KM, Randall RL, Jones KB, Lucas D, Rosenberg A, Thomas D, Lessnick SL, Schiffman J(2012)Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma.  Cancer Genetics, 205(7-8),391-404
7. Schiffman JD, Wright (2011)Ewing's Sarcoma and Second Malignancies.  Sarcoma, 2011736841
8. Jahromi MS, Jones KB, Schiffman J(2011)Copy Number Alterations and Methylation in Ewing's Sarcoma.  Sarcoma, 2011362173
9. Rudner LA, Brown KH, Dobrinski KP, Bradley DF, Garcia MI, Smith AC, Downie JM, Meeker ND, Look AT, Downing JR, Gutierrez A, Mullighan CG, Schiffman JD, Lee C, Trede NS, Frazer J(2011)Shared acquired genomic changes in zebrafish and human T-ALL.  Oncogene, 30(41),4289-96
10. Villani A, Tabori U, Schiffman J, Shlien A, Druker H, Novokmet A, Finlay J, Malkin (2011)Biochemical and imaging surveillance among germline TP53 mutation carriers with Li-Fraumeni syndrome  The Lancet Oncology, 12(6),559-67
11. Hao HX, Khalimonchuk O, Schraders M, Dephoure N, Bayley JP, Kunst H, Devilee P, Cremers CW, Schiffman JD, Bentz BG, Gygi SP, Winge DR, Kremer H, Rutter (2009)SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma.  Science, 325(5944),1139-42
12. Schiffman JD, Chun N, Fisher PG, Dahl GV, Ford JM, Eggerding F(2008)Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.  Pediatric Blood & Cancer, 50(4),914-6

Video